Changes to the website
Sponsored By
Cedars-Siani Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 1 to 25 of about 4866

Next 25
Website Changes
09/14/2019 DeAngelis named MSK physician-in-chief, chief medical officer
09/13/2019 Tocagen Reports Results of Toca 5 Phase 3 Trial in Recurrent Brain Cancer
09/11/2019 Frankly Speaking About Brain Tumors
09/11/2019 Publication Reports Clinical Efficacy of ONC201 in Expanded Access H3 K27M-mutant Glioma Patients
09/09/2019 Bristol-Myers Squibb`s Opdivo fails 3rd straight test in tough-to-treat brain cancer
09/09/2019 Novocure Announces 27 Presentations at the American Society for Radiation Oncology 2019 Annual Meeting
08/30/2019 Musella Foundation awards a pediatric brain tumor research grant!
08/15/2019 DelMar Pharmaceuticals Reports Updated Results on Twenty Patients from the Phase 2 Clinical Trial of VAL-083 as First-Line Treatment in Newly-Diagnosed MGMT-Unmethylated Glioblastoma MultiForme (GBM)
08/15/2019 Attend an Optune Open House
08/03/2019 Young adults diagnosed with high grade gliomas: Patterns of care, outcomes, and impact on employment.
08/03/2019 Validation of an effective implantable pump-infusion system for chronic convection-enhanced delivery of intracerebral topotecan in a large animal model.
07/29/2019 Valerie Harper to stay out of hospice care, husband says
07/29/2019 Long-term survival in patients with recurrent glioblastoma treated with bevacizumab: a multicentric retrospective study.
07/29/2019 Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy.
07/26/2019 Musella Foundation Brain Tumor Copay Program has reopened!
07/20/2019 A Randomized Double-Blind Placebo-Controlled Phase 2 Trial Of Dendritic Cell Vaccine ICT-107 In Newly Diagnosed Patients With Glioblastoma
07/19/2019 Study hints at why an aggressive form of brain cancer is hard to treat
07/19/2019 A New Method for Ethical and Efficient Evidence Generation for Off-Label Medication Use in Oncology (A Case Study in Glioblastoma)
07/18/2019 Medicare Releases Final Local Coverage Determination Providing Coverage of Optune® for Newly Diagnosed Glioblastoma
07/17/2019 Electricity helps control man’s brain tumor
07/17/2019 ImmunoCellular Therapeutics Announces Asset Purchase Agreement with Private Biotechnology Company
07/16/2019 GBM Awareness Day This Wednesday July 17th!
07/16/2019 Neoadjuvant Anti-PD-1 Immunotherapy Leads to Survival Benefit in Recurrent Glioblastoma
07/16/2019 Attend an Optune Open House.
07/15/2019 Phase II study of Dovitinib in recurrent glioblastoma.



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740